Differential S-phase progression after irradiation of p53 functional versus non-functional tumour cells

1. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-11.Search in Google Scholar

2. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992; 89: 7491-5.10.1073/pnas.89.16.7491Search in Google Scholar

3. Howard A, Pelc SR. Synthesis of deoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Heredity 1953; 6: 261-73.Search in Google Scholar

4. Little JB. Delayed initiation of DNA synthesis in irradiated human diploid cells. Nature 1968; 218: 1064-5.10.1038/2181064a0Search in Google Scholar

5. Cuddihy AR, Bristow RG. The p53 protein family and radiation sensitivity: Yes or no? Cancer Met Rev 2004; 23: 237-57.Search in Google Scholar

6. Zölzer F, Streffer C. Quiescence in S-phase and G1 arrest induced by irradiation and/or hyperthermia in six human tumour cell lines of different p53 status. Int J Radiat Biol 2000; 76: 717-25.10.1080/095530000138394Search in Google Scholar

7. Terasima T, Tolmach LJ. Variations in several responses of HeLa cells to xirradiation during the division cycle. Biophys J 1963; 3: 11-33.10.1016/S0006-3495(63)86801-0Search in Google Scholar

8. Zölzer F, Jagetia G, Streffer C. G2-block after irradiation of cells with different p53 status. Strahlen Onkol, June 14 2014. [Epub ahead of print]. doi 10.1007/s00066-014-0690-510.1007/s00066-014-0690-5Search in Google Scholar

9. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 1995; 92: 8493-7.10.1073/pnas.92.18.8493Search in Google Scholar

10. Stewart N, Hicks GG, Paraskevas F, Mowat M. Evidence for a second cell cycle block at G2/M by p53. Oncogene 1995; 10: 109-15.Search in Google Scholar

11. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282: 1497-501.10.1126/science.282.5393.1497Search in Google Scholar

12. Solberg Landsverk K, Patzke S, Rein ID, Stokke C, Lyng H, De Angelis PM, Stokke T. Three independent mechanisms for arrest in G2 after ionizing radiation. Cell Cycle 2011; 10: 819-29.10.4161/cc.10.5.14968Search in Google Scholar

13. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene 2001; 20: 1803-15.10.1038/sj.onc.1204252Search in Google Scholar

14. Stark GR, Taylor WR. Control of the G2/M transition. Mol Biotech 2006; 32: 227-48.10.1385/MB:32:3:227Search in Google Scholar

15. Busse PM, Bose SK, Jones RW, Tolmach LJ. The action of caffeine on X-irradiated HeLa cells. III. Enhancement of X-ray-induced killing during G2 arrest. Radiat Res 1978; 76: 292-307.10.2307/3574780Search in Google Scholar

16. Powell SN, DeFrank JS, Connell P, Eogan M, Preffer F, Dombkowski D, et al. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res 1995; 55: 1643-8.10.1016/0360-3016(95)97825-LSearch in Google Scholar

17. Musk SR. Reduction of radiation-induced cell cycle blocks by caffeine does not necessarily lead to increased cell killing. Radiat Res 1991; 125: 262-6.10.2307/3578108Search in Google Scholar

18. Schwartz JL, Cowan J, Grdina DJ, Weichselbaum RR. Attenuation of G2- phase cell cycle checkpoint control is associated with increased frequencies of unrejoined chromosome breaks in human tumor cells. Radiat Res 1996; 146: 139-43.10.2307/3579585Search in Google Scholar

19. Iliakis G, Wang Y, Guan J, Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 2003; 22: 5834-47.10.1038/sj.onc.1206682Search in Google Scholar

20. Painter RB, Young BR. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci USA 1980; 77: 7315-710.1073/pnas.77.12.7315Search in Google Scholar

21. Larner JM, Lee H, Hamlin JL. S phase damage sensing checkpoints in mammalian cells. Cancer Surv 1997; 29: 25-45.Search in Google Scholar

22. Morgan SE, Lovly C, Pandita TK, Shiloh Y, Kastan MB. Fragments of ATM which have dominant-negative or complementing activity. Mol Cell Biol 1997; 17: 2020-9.10.1128/MCB.17.4.2020Search in Google Scholar

23. Fei P, El-Deiry WS. P53 and radiation responses. Oncogene 2003; 22: 5774-83.10.1038/sj.onc.1206677Search in Google Scholar

24. Bartek J, Lukas C, Lukas J. Checking on DNA damage in S phase. Nature Rev Mol Cell Biol 2004; 5: 792-804.10.1038/nrm1493Search in Google Scholar

25. Liu WF, Yu SS, Chen GJ, Li YZ. DNA damage checkpoint, damage repair, and genome stability. Acta Gen Sin 2006; 33: 381-90.10.1016/S0379-4172(06)60064-4Search in Google Scholar

26. Lee AY, Chiba T, Truong LN, Cheng AN, Do J, Cho MJ, et al. Dbf4 is direct downstream target of ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) protein to regulate intra-S-phase checkpoint. J Biol Chem 2012; 287: 2531-43.10.1074/jbc.M111.291104Search in Google Scholar

27. Falck J, Petrini JH, Williams BR, Lukas J, Bartek J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nature Gen 2002; 30, 290-4.10.1038/ng845Search in Google Scholar

28. Willis N, Rhind N. Regulation of DNA replication by the S-phase DNA damage checkpoint. Cell Div 2009; 4: 13.10.1186/1747-1028-4-13Search in Google Scholar

29. Dai Y, Grant S. New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res 2010; 16: 376-83.10.1158/1078-0432.CCR-09-1029Search in Google Scholar

30. Yazdi PT, Wang Y, Zhao S, Patel N, Lee EY, Qin J. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev 2002; 16: 571-82.10.1101/gad.970702Search in Google Scholar

31. Luo H, Li Y, Mu JJ, Zhang J, Tonaka T, Hamamori Y, et al. Regulation of intra-S phase checkpoint by ionizing radiation (IR)-dependent and IR-independent phosphorylation of SMC3. J Biol Chem 2008; 283: 19176-83.10.1074/jbc.M802299200Search in Google Scholar

32. Zhou XY, Wang X, Hu B, Guan J, Iliakis G, Wang Y. An ATM-independent S-phase checkpoint response involves CHK1 pathway. Cancer Res 2002; 62: 1598-603.Search in Google Scholar

33. Sørensen CS, Syljuåsen RG, Falck J, Schroeder T, Rönnstrand L, Khanna KK, Zhou BB, Bartek J, Lukas J. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 2003; 3: 247-58.10.1016/S1535-6108(03)00048-5Search in Google Scholar

34. Cho YJ, Liang P. Killin is a p53-regulated nuclear inhibitor of DNA synthesis. Proc Natl Acad Sci USA 2008; 105: 5396-401.10.1073/pnas.0705410105229108018385383Search in Google Scholar

35. Cho YJ, Liang P. S-phase-coupled apoptosis in tumor suppression. Cell Mol Life Sci 2008; 68: 1883-96.Search in Google Scholar

36. Demidova AR, Aau MY, Zhuang L, Yu Q. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control. J Biol Chem 2009; 284: 4132-9.10.1074/jbc.M80811820019060337Search in Google Scholar

37. Vigneron A, Cherier J, Barré B, Gamelin E, Coqueret O. The cell cycle inhibitor p21waf1 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression. J Biol Chem 2006; 281: 34742-50.10.1074/jbc.M60249220016923815Search in Google Scholar

38. Zhu Y, Alvarez C, Doll R, Kurata H, Schebye XM, Parry D, Lees E. Intra-S-phase checkpoint activation by direct CDK2 inhibition. Mol Cell Biol 2004; 24: 6268-77.10.1128/MCB.24.14.6268-6277.2004Search in Google Scholar

39. Weininger J, Guichard M, Joly AM, Malaise EP, Lachet B. Radiosensitivity and growth parameters in vitro of three human melanoma cell strains. Int J Radiat Biol 1978; 34: 285-90.Search in Google Scholar

40. Fogh J, Bean MA, Brüggen J, Fogh H, Fogh JM, Hammar SP, et al. Comparison of a human tumor cell line before and after growth in the nude mouse. In: Fogh J, Giovanella B, editors. The nude mouse in experimental and clinical research. New York: Academic Press; 1978. p. 215-45.Search in Google Scholar

41. Zölzer F, Hillebrandt S, Streffer C. Radiation induced G1-block and p53 status in six human cell lines. Radiother Oncol 1995; 37: 20-8.10.1016/0167-8140(95)01618-QSearch in Google Scholar

42. Albino AP, Vidal MJ, McNutt NS, Shea CR, Prieto VG, Nanus DM, et al. Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res 1994; 4: 35-45.10.1097/00008390-199402000-00006Search in Google Scholar

43. Böhnke A, Westphal F, Schmidt A, El-Awady RA, Dahm-Daphi J. Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells. Int J Radiat Biol 2004; 80: 53-63.10.1080/09553000310001642902Search in Google Scholar

44. Binder AB, Serafin AM, Bohm LJ. Abrogation of G(2)/M-phase block enhances the cytotoxicity of daunorubicin, melphalan and cisplatin in TP53 mutant human tumor cells. Radiat Res 2000; 154: 640-9.10.1667/0033-7587(2000)154[0640:AOGMPB]2.0.CO;2Search in Google Scholar

45. Stuschke M, Budach V, Sack H. Radioresponsiveness of human glioma, sarcoma, and breast cancer spheroids depends on tumour differentiation. Int J Radiat Oncol Biol Phys 1993; 27: 627-36.10.1016/0360-3016(93)90389-DSearch in Google Scholar

46. Wurm R, Ketel B, Schröder G, Sinn B, Schlenger L, Wolf G, et al. Strahlenempfindlichkeit nach kombination von bestrahlung und koffein. Strahlenther Onkol 1997; 173: 614.Search in Google Scholar

47. Zölzer F, Uma Devi P, Streffer C. Determination of potential doubling times in human melanoma cell cultures subjected to irradiation and/or hyperthermia by flow cytometry. Radiat Res 1994; 138: 451-9.10.2307/3578695Search in Google Scholar

48. Zölzer F, Streffer C, Pelzer T. Induction of quiescent S-phase cells by irradiation and/or hyperthermia. I. Time and dose dependence. Int J Radiat Biol 1993; 63: 69-76.10.1080/09553009314550091Search in Google Scholar

49. Begg AC, Moonen L, Hofland I, Dessing M, Bartelink H. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations. Radiother Oncol 1988; 11: 337-47.10.1016/0167-8140(88)90205-8Search in Google Scholar

50. Zölzer F, Streffer C. G2-phase delays after irradiation and/or heat treatment as assessed by two-parameter flow cytometry. Radiat Res 2001; 155: 50-6.10.1667/0033-7587(2001)155[0050:GPDAIA]2.0.CO;2Search in Google Scholar

51. Zhou J, Prives C. Replication of damaged DNA in vitro is blocked by p53. Nucl Acid Res 2003; 31: 3881-92.10.1093/nar/gkg46816598212853603Search in Google Scholar

52. Mirzayans R, Aubin RA, Bosnich W, Blattner WA, Paterson MC. Abnormal pattern of post-γ-ray DNA replication in radioresistant fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome. Br J Cancer 1995; 71: 1221-30. 10.1038/bjc.1995.23720338547779715Search in Google Scholar